Skip to content

Bilateral superficial cervical plexus block for post-operative analgesia in thyroid surgeries using ropivacaine(0.2%) with or without dexmedetomidine

A prospective, double blind, randomised control study on bilateral superficial cervical plexus block using ropivacaine (0.2%) with and without dexmedetomidine (1mcg/kg)for post-operative analgesia in thyroid surgeries

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016018
Enrollment
60
Registered
2018-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E079- Disorder of thyroid, unspecified Health Condition 2: E079- Disorder of thyroid, unspecified

Interventions

Intervention1: dexmedetomidine with ropivacaine: dexmedetomidine (1mcg/kg) with ropivacaine (0.2%)for post-operative analgesia in thyroid surgeries Intervention2: ropivacaine: ropivacaine (0.2%)for su

Sponsors

MB hospital Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: the study conducted on 60 patients of ASA Grade I & II of either sex, aged 18 to 60 years, having a euthyroid state, who undergone elective thyroid surgeries under general anesthesia and after completion of surgery bilateral superficial cervical plexus block given.

Exclusion criteria

Exclusion criteria: patient refusal,age 2,patient havong severe respiratory,cardiac or renal disorders,and acute psychiatric illness,infection at the injection site,allergy to agent used,morbid obesity (bmi >35),coagulation disorders

Design outcomes

Primary

MeasureTime frame
Postoperative analgesia. To determine the adverse effects, if any of ropivacaine and dexmedetomidine. To study the post-operative pain management, rescue analgesic requirement, sedation in patients, hospital stay and patient comfort. Timepoint: to study post-operative analgesia at 0hour,4hour,8hour,12hour and 24hour

Secondary

MeasureTime frame
To study the post-operative pain management, rescue analgesic requirement, sedation in patients, hospital stay and patient comfort.Timepoint: to study post-operative analgesia at 0hour,4hour,8hour,12hour and 24hour

Countries

India

Contacts

Public ContactDrLalit Kumar Raiger

RNT Medical College,Udaipur

drlalitkumar@hotmail.com9414352823

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026